Bevacizumab
بواسیزوماب
🎗️ Antineoplastic And Immunomodulating AgentsAnti-VEGF antibody
Market / country: 🇺🇸 USA
Avastin (US)
🧮 Dose calculator
Colorectal cancer · Regimen source: FDA Avastin · 2.2
- • With FOLFOX4: 10 mg/kg every 2 weeks; or 7.5 mg/kg every 3 weeks second-line. Not within 28 days before or after major surgery. FDA Avastin · 2.2FDA Avastin · 2.1
- • Only under an oncologist; protocol, cycle interval and adjustment rest with the treating team. FDA Avastin · 2
Enter age and weight.
🛡️ Safety & information
Warnings
- • GI perforation and fistula; wound-healing complications; haemorrhage; arterial and venous thromboembolism; hypertension; PRES; proteinuria; infusion reactions; ovarian failure; heart failure. FDA Avastin · 5
Formulations
- 25 mg/mL (100 mg/4 mL, 400 mg/16 mL) — injection 🇺🇸 USA FDA Avastin · 3
👥 Special populations
- 🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Avastin · 8.1
“Risk Summary Based on findings from animal studies and its mechanism of action [see Clinical Pharmacology (12.1) ], Avastin may cause fetal harm in pregnant women.”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Avastin · 8.2
“Because of the potential for serious adverse reactions in breastfed infants, advise women not to breastfeed during treatment with Avastin and for 6 months after the last dose.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Avastin · 8.4
“The safety and effectiveness of Avastin in pediatric patients have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Avastin · 8.5
“… ATE was greater in patients ≥ 65 years (8% vs. 3%) as compared to patients < 65 years (2% vs. 1%) [see Warnings and Precautions (5.4) ].”
- ⚥ Females & males of reproductive potentialUse with caution
Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Avastin · 8.3
“Contraception Females Avastin may cause fetal harm when administered to a pregnant woman [see Use in Specific Populations (8.1) ] .”
🔗 Reference links
- FDA (approval record)BLA125085
- DailyMed (FDA label)FDA Avastin
- MedlinePlus (NIH)Bevacizumab Injection
- WHO ATC/DDDL01FG01
- Darooyab (Iran)Bevacizumab
🇮🇷 Registered in Iran Darooyab · G-952/Bevacizumab
Dosage forms with Iranian generic codes, per Darooyab.
- 11410 · BEVACIZUMAB 100MG/4ML AMP · آمپول بواسیزومب ۱۰۰ میلیگرم / ۴ میلیلیتر
- 05615 · BEVACIZUMAB 100MG/4ML VIAL · ویال بواسیزومب ۱۰۰ میلیگرم / ۴ میلیلیتر
- 05616 · BEVACIZUMAB 400MG/16ML VIAL · ویال بواسیزومب ۴۰۰ میلیگرم / ۱۶ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Avastin · 3FDA Avastin · 2.2FDA Avastin · 2.1FDA Avastin · 2FDA Avastin · 2.3FDA Avastin · 2.4FDA Avastin · 2.5FDA Avastin · 2.6FDA Avastin · 5FDA Avastin · SPL approval / marketing categoryFDA Avastin · 8.1FDA Avastin · 8.2FDA Avastin · 8.4FDA Avastin · 8.5FDA Avastin · 8.3
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-952/Bevacizumab
- Clinical review⚠ Unverified